Fusion Pharmaceuticals FUSN
$ 21.55
0.0%
Quarterly report 2024-Q1
added 05-07-2024
Country |
Canada |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. John F. Valliant |
Employees in the company |
37 |
Shares |
65.6 M |
Market Cap[1] |
$ 1.41 B |
EBITDA (LTM) |
$ -102 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.